Convergence Investment Partners’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-48,401
Closed -$917K 278
2025
Q4
$917K Buy
48,401
+2,779
+6% +$51.5K 0.18% 174
2025
Q3
$850K Buy
+45,622
New +$852K 0.19% 172
2019
Q2
Sell
-93,165
Closed -$1.81M 373
2019
Q1
$1.81M Buy
93,165
+23,436
+34% +$444K 0.4% 91
2018
Q4
$1.15M Buy
+69,729
New +$1.4M 0.26% 137
2018
Q2
Sell
-2
Closed 785
2018
Q1
$0 Buy
+2
New +$35 ﹤0.01% 1057
2017
Q4
Sell
-19,545
Closed -$429K 339
2017
Q3
$429K Sell
19,545
-132,917
-87% -$3M 0.06% 286
2017
Q2
$3.67M Buy
152,462
+109,408
+254% +$2.78M 0.54% 48
2017
Q1
$1.2M Buy
+43,054
New +$1.13M 0.17% 223
2016
Q4
Sell
-100,808
Closed -$2.54M 371
2016
Q3
$2.54M Buy
+100,808
New +$2.41M 0.37% 91

Other funds holding SBRA

Convergence Investment Partners's SBRA Position: Q1 2026 in Review

Convergence Investment Partners sold out of Sabra Healthcare REIT (SBRA) in Q1 2026, closing a stake of 48,401 shares — an estimated $917K sold.

Convergence Investment Partners first reported a position in SBRA in Q3 2016 and held it in 9 quarters. The position peaked at $3.67M in Q2 2017. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

  • Convergence Investment Partners reported no remaining Sabra Healthcare REIT position as of Q1 2026 after selling out during the quarter.
  • Convergence Investment Partners sold 48,401 Sabra Healthcare REIT shares in Q1 2026, an estimated $917K.
  • Convergence Investment Partners first reported a position in Sabra Healthcare REIT in Q3 2016 and held it in 9 quarters.
  • Convergence Investment Partners's Sabra Healthcare REIT position peaked at $3.67M in Q2 2017.
  • 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on Convergence Investment Partners's 13F filing for Q1 2026, filed 7 May 2026.